Genocea BiosciencesGNCAQ
13F holders, Q2 2024 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Genocea Biosciences Inc. (GNCAQ) in their 13F filings, unchanged from Q1 2024. 0 opened new positions and 0 sold out. The largest holder was Madison Park Capital Advisors, LLC ($0).
- Company
- Genocea Biosciences Inc.
- CUSIP
- 372427401
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Madison Park Capital Advisors, LLC | 0.00% | No change | 10,000 | $0 |
"% of holder's portfolio" is GNCAQ's weight in each manager's 13F, not the share of Genocea Biosciences Inc. the manager owns.